Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 28/10/2009
PIL Miacalcic 200 IU Nasal Spray

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 12/02/2009 and displayed until 28/10/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 07/12/2007 and displayed until 12/02/2009
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to side-effects
Updated on 17/01/2006 and displayed until 07/12/2007
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to warnings or special precautions for use
Updated on 11/04/2005 and displayed until 17/01/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to drug interactions
  • Change of contra-indications
Updated on 10/06/2003 and displayed until 11/04/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/06/2003 and displayed until 10/06/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/11/2001 and displayed until 05/06/2003
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   calcitonin (salmon)